Genmab A/S Announces Share Buy-back Program Transactions
Ticker: GNMSF · Form: 6-K · Filed: Jun 23, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, capital-allocation, disclosure
TL;DR
Genmab's buying back shares, check out the announcement.
AI Summary
On June 23, 2025, Genmab A/S announced transactions related to its share buy-back program. This Form 6-K filing incorporates by reference previous registration statements and includes a company announcement detailing these share buy-back activities.
Why It Matters
This filing provides transparency on Genmab's capital allocation strategy and its ongoing efforts to return value to shareholders through share repurchases.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share buy-back program activities and does not introduce new material risks.
Key Players & Entities
- Genmab A/S (company) — Registrant
- June 23, 2025 (date) — Announcement Date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing is to report on transactions in connection with Genmab A/S's share buy-back program, as announced on June 23, 2025.
What exhibit is included in this filing?
Exhibit 99.1 is included, which is a Company Announcement dated June 23, 2025, detailing Transactions in Connection with Share Buy-back Program.
Does this filing supersede previous registration statements?
This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
What is the principal executive office address for Genmab A/S?
The address of the principal executive offices is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
What is the SEC file number for Genmab A/S?
The SEC file number for Genmab A/S is 001-38976.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 23, 2025 regarding GENMAB A/S (GNMSF).